Novo Nordisk’s Wegovy and copyright, both equally powered by semaglutide, have revolutionized obesity cure through unparalleled weight loss success.This led Novo Nordisk to perform additional exploration into larger dosages of semaglutide specifically for weight management.$100 billion. That’s the amount the weight loss drug sector will probabl